Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001780030-26-000004

Chief Financial Officer bought 17,413 shares at an average $23.31 ($405,921)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
STEPHENSON BRIAN C Chief Financial Officer 2026-06-22 Purchase +1,797 $20.23 $36,353 1,797 I: show line 1 in the form
STEPHENSON BRIAN C Chief Financial Officer 2026-06-22 Purchase +1,118 $20.82 $23,277 2,915 I: show line 2 in the form
STEPHENSON BRIAN C Chief Financial Officer 2026-06-22 Purchase +1,583 $22.40 $35,459 4,498 I: show line 3 in the form
STEPHENSON BRIAN C Chief Financial Officer 2026-06-22 Purchase +3,329 $23.28 $77,499 7,827 I: show line 4 in the form
STEPHENSON BRIAN C Chief Financial Officer 2026-06-22 Purchase +356 $23.95 $8,526 8,183 I: show line 5 in the form
STEPHENSON BRIAN C Chief Financial Officer 2026-06-23 Purchase +6,836 $24.12 $164,884 15,019 I: show line 6 in the form
STEPHENSON BRIAN C Chief Financial Officer 2026-06-23 Purchase +1,969 $24.84 $48,910 16,988 I: show line 7 in the form
STEPHENSON BRIAN C Chief Financial Officer 2026-06-23 Purchase +425 $25.91 $11,012 17,413 I: show line 8 in the form
Open-market purchases · 17,413 sh · avg $23.31 · $405,921
Loading xslF345X06/form4-06242026_100604.xml…